Fred Hutchinson Cancer Research Center

Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function

Summaries of recent Fred Hutch research findings and other news

Newswise — SEATTLE — May 4, 2021 — Below are summaries of recent Fred Hutch research findings and other news.

If you are covering news at the upcoming American Society of Gene & Cell Therapy, American Society of Clinical Oncology, or other conferences, feel free to reach out to our media team for help sourcing experts: [email protected].

Latest Fred Hutch research on COVID-19 In the past month, our scientists have published findings on how SARS-CoV-2 mutates and what that may mean for vaccine efficacy, how machine learning may help dampen the cytokine storm from COVID-19 and comparing immune responses from infection versus vaccination.

Event: Pathways to Equity Symposium Fred Hutch’s Office of Community Outreach and Engagement will be hosting their annual Pathways to Equity Symposium on Friday, May 2, 8:30am-12:30pm PT. Speakers will discuss racial/social justice, health equity and community engagement. Registration is free. RSVP here.

Hutch researchers discover neutralizing antibodies to parainfluenza A team of researchers led by Dr. Justin Taylor describes how they isolated five different antibodies that, in lab dish studies, potently protect against human parainfluenza virus type III, or HPIV3. Their work was published on April 20 in the open access journal mAbs.

Dr. Julie Overbaugh elected to National Academy of Sciences Virologist Dr. Julie Overbaugh, who studies factors that shape HIV transmission, was elected to the National Academy of Sciences. Overbaugh is one of 120 new members, including a record number of women, elected by their peers in recognition of their distinguished and continuing achievements in research.

Careful pruning guides neuron function Dr. Aakanksha Singhvi used tiny worms with well-mapped nervous systems in her latest work that was published in the journal eLife. She and a graduate student, Stephan Raiders, collaborated to learn how the role of accessory brain cells called glial cells support neuron function.

Seeking to expand targeted therapy for lung cancer Lung cancer researcher Dr. Alice Berger received a National Institutes of Health MERIT Award that will support her efforts to extend advances to more patients with this cancer. Berger’s MERIT Award will fund seven years of investigations into a gene that’s mutated in a subset of non-small cell lung cancer and other tumors, including some leukemias. Her ultimate goal is to extend the power of targeted therapy to more patients with lung cancer.

Event: B+T = Immunotherapy Drs. Jim Boonyaratanakornkit, Stan Riddell and Shivani Srivastava joined Dr. Bruce Clurman, Fred Hutch executive vice president and deputy director, to discuss their work studying immune cells to develop treatments for cancers and infectious diseases. Dr. Rachel Bender Ignacio also gave us an update on COVID-19 treatments happening at the Hutch’s COVID-19 Clinical Research Center. The event is part of the Hutch public science series, Science Says. Our next Science Says, on the importance of diversity and equity in science, will be June 15. Register here.

Obliteride 2021 gears up for second virtual season

Fred Hutch’s Statement on the Derek Chauvin Verdict

Essential workers illustrate the Heart of the Hutch

 

# # #

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.




Filters close

Showing results

110 of 5636
Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:00 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.

Released: 13-May-2021 9:00 AM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Newswise

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 13-May-2021 8:00 AM EDT
Dental procedures during pandemic are no riskier than a drink of water
Ohio State University

A new study’s findings dispel the misconception that patients and providers are at high risk of catching COVID-19 at the dentist’s office.

Newswise:Video Embedded lung-damage-not-the-culprit-for-post-covid-exercise-limitations
VIDEO
Released: 13-May-2021 7:00 AM EDT
Lung Damage Not the Culprit for Post-COVID Exercise Limitations
American Physiological Society (APS)

A new study suggests the lungs may not be the main factor that reduce exercise ability in people recovering from severe COVID-19. Anemia and muscle dysfunction also play a role. The study is published ahead of print in the Journal of Applied Physiology. It was chosen as an APSselect article for May.


Showing results

110 of 5636

close
1.75155